Source link : https://newshealth.biz/health-news/rivaroxaban-or-combo-therapy-a-winner-for-all-ages/
The efficacy and safety of rivaroxaban monotherapy are consistent across all age groups of patients with atrial fibrillation and stable coronary artery disease, a study confirms. Medscape Medical News Source link : https://www.medscape.com/viewarticle/rivaroxaban-alone-comparable-combination-therapy-across-age-2025a1000lxm?src=rss Author : Publish date : 2025-08-20 02:59:00 Copyright for syndicated content belongs to the linked Source.
The post Rivaroxaban or Combo Therapy: A Winner for All Ages? first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-20 02:59:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8